SLC6A3 and Parkinson disease: Moreover, although striatal DAT binding has been previously reported to be lower in PSP than in PD and MSA (Badoud et al. 2016; Kaasinen et al. 2019), it is unknown whether the difference reflects the pathophysiological differences between diseases, since disease duration and severity were not consistent among the diagnoses in these studies.